Key result
A 70-year-old male with methanol toxicity developed expanding hemorrhagic brain lesions after hemodialysis, questioning the role of routine systemic heparinization in this setting.
Why the study?
Does systemic heparinization during hemodialysis contribute to brain hemorrhage in patients with methanol toxicity?
Case Report (n=1)
Does systemic heparinization during hemodialysis contribute to brain hemorrhage in patients with methanol toxicity?
This case report questions the safety of routine systemic heparinization during hemodialysis for methanol toxicity due to the risk of intracranial hemorrhage.
May warrant caution with anticoagulation during HD for methanol poisoning; leaves open causal association pending controlled data.
Brain hemorrhages are rare complications of acute methanol poisoning. There is a debate on association of brain hemorrhage in methanol toxicity and application of systemic anticoagulation during hemodialysis (HD). A 70-year-old male presented to us with severe metabolic acidosis and a methanol level of 7.6 mg/dL. Ethanol and folinic acid were administered, and HD was performed. Brain computed tomography (CT) scan which was normal on presentation showed extensive bilateral subcortical supratentorial hypodensities on the 3rd day after commencing the treatment. However, the next CT scan performed 2 weeks later revealed expanding hemorrhagic transformation in previous hypodensities. Hemorrhagic changes could not be explained by patient's coagulation profile on the 3rd day. Anticoagulation agents such as heparin are used routinely during a dialysis session to prevent clot formation in dialysis circuits. This case is possibly questioning the role of heparin in hemorrhagic brain lesions of methanol intoxication.
No takes yet. Share an insight, caveat, or question.
Hassanian‐Moghaddam et al. (2017) conducted a case report in Methanol toxicity (n=1). Heparin during hemodialysis was evaluated on Intracranial hemorrhage. A 70-year-old male with methanol toxicity developed expanding hemorrhagic brain lesions after hemodialysis, questioning the role of routine systemic heparinization in this setting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: